• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Very Early Development and Recognition of Coronary Involvement in a Febrile Infant with Typical Signs of Kawasaki Disease.一名具有典型川崎病体征的发热婴儿冠状动脉受累的极早期发展与识别
Mediterr J Hematol Infect Dis. 2018 Jun 20;10(1):e2018037. doi: 10.4084/MJHID.2018.037. eCollection 2018.
2
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.多中心、随机、开放标签、盲终点评估的皮质类固醇加静脉注射免疫球蛋白(IVIG)和阿司匹林与 IVIG 和阿司匹林预防川崎病(KD)冠状动脉瘤(CAA)的试验:KD CAA 预防(KD-CAAP)试验方案。
Trials. 2023 Jan 26;24(1):60. doi: 10.1186/s13063-022-07051-9.
3
Refractory Kawasaki Disease-a Challenge for the Pediatrician.难治性川崎病——儿科医生面临的挑战
SN Compr Clin Med. 2021;3(3):855-860. doi: 10.1007/s42399-021-00775-w. Epub 2021 Jan 28.
4
A Challenging Diagnosis of Kawasaki Disease Shock Syndrome Complicated by Bilateral Pleural Effusion: A Case Report and Literature Review.川崎病休克综合征合并双侧胸腔积液的疑难诊断:一例报告及文献复习
Cureus. 2023 Nov 29;15(11):e49671. doi: 10.7759/cureus.49671. eCollection 2023 Nov.
5
ATYPICAL KAWASAKI DISEASE.非典型川崎病
Med Pregl. 2016 Jan-Feb;69(1-2):53-7. doi: 10.2298/mpns1602053r.
6
Atypical Kawasaki Disease Presentation in a Previously Healthy Infant: A Diagnostic Challenge.一名既往健康婴儿的非典型川崎病表现:诊断挑战
Cureus. 2023 Oct 9;15(10):e46748. doi: 10.7759/cureus.46748. eCollection 2023 Oct.
7
An Adult Kawasaki Disease with Coronary Artery Involvement: A Unique Case Report and Literature Review.一例累及冠状动脉的成人川崎病:病例报告及文献综述
Cureus. 2019 Aug 30;11(8):e5529. doi: 10.7759/cureus.5529.
8
Incomplete Kawasaki Disease with Peripheral Facial Nerve Palsy and Lung Nodules: A Case Report and Literature Review.伴有周围性面神经麻痹和肺结节的不完全川崎病:一例报告及文献复习
Children (Basel). 2023 Apr 3;10(4):679. doi: 10.3390/children10040679.
9
Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.川崎病患者早期静脉注射免疫球蛋白治疗。
J Pediatr. 2002 Apr;140(4):450-5. doi: 10.1067/mpd.2002.122469.
10
Mechanism of HMGB1-RAGE in Kawasaki disease with coronary artery injury.HMGB1-RAGE 在川崎病合并冠状动脉损伤中的作用机制。
Eur J Med Res. 2020 Mar 17;25(1):8. doi: 10.1186/s40001-020-00406-5.

引用本文的文献

1
Association between gene polymorphisms and coronary artery lesion in Kawasaki disease.川崎病基因多态性与冠状动脉病变的相关性
Front Med (Lausanne). 2023 Jul 27;10:1193303. doi: 10.3389/fmed.2023.1193303. eCollection 2023.
2
Mechanism of HMGB1-RAGE in Kawasaki disease with coronary artery injury.HMGB1-RAGE 在川崎病合并冠状动脉损伤中的作用机制。
Eur J Med Res. 2020 Mar 17;25(1):8. doi: 10.1186/s40001-020-00406-5.

本文引用的文献

1
The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness.川崎病冠状动脉异常的预防:皮质类固醇疗效的荟萃分析。
J Microbiol Immunol Infect. 2018 Jun;51(3):321-331. doi: 10.1016/j.jmii.2017.08.012. Epub 2017 Sep 6.
2
Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.川崎病患儿冠状动脉进行性扩张的危险因素及影响
BMC Pediatr. 2017 Jun 6;17(1):139. doi: 10.1186/s12887-017-0895-8.
3
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理:美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
4
Asymptomatic Kawasaki Disease in a 3-Month-Old Infant.一名3个月大婴儿的无症状川崎病
Pediatrics. 2016 Aug;138(2). doi: 10.1542/peds.2015-3936. Epub 2016 Jul 1.
5
Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease.静脉注射免疫球蛋白、药物基因组学与川崎病。
J Microbiol Immunol Infect. 2016 Feb;49(1):1-7. doi: 10.1016/j.jmii.2014.11.001. Epub 2014 Nov 11.
6
Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database.免疫球蛋白抵抗型川崎病的流行病学:来自一个大型全国数据库的结果
Pediatr Cardiol. 2015 Feb;36(2):374-8. doi: 10.1007/s00246-014-1016-1. Epub 2014 Sep 2.
7
Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011.韩国川崎病的流行病学特征:2009 - 2011年全国性调查数据
Pediatr Infect Dis J. 2014 Jan;33(1):24-7. doi: 10.1097/INF.0000000000000010.
8
Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey.日本川崎病的流行病学特征:2009-2010 年全国调查结果。
J Epidemiol. 2012;22(3):216-21. doi: 10.2188/jea.je20110126. Epub 2012 Mar 10.
9
Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas.川崎病:一种充满未解之谜的有趣疾病。
Pediatr Rheumatol Online J. 2011 Jul 20;9:17. doi: 10.1186/1546-0096-9-17.
10
Kawasaki syndrome and concurrent Coxsackie virus B3 infection.川崎病合并柯萨奇病毒 B3 感染。
Rheumatol Int. 2012 Dec;32(12):4037-40. doi: 10.1007/s00296-010-1613-0. Epub 2010 Oct 30.

一名具有典型川崎病体征的发热婴儿冠状动脉受累的极早期发展与识别

Very Early Development and Recognition of Coronary Involvement in a Febrile Infant with Typical Signs of Kawasaki Disease.

作者信息

Buonsenso D, Cristaldi S, Reale A, de Jacobis I Tarissi, Granata L, Marchesi A

机构信息

Pediatric Emergency Department, Bambino Gesù Children's Hospital, Institute for Research and Health Care (IRCCS), Rome, Italy.

Pediatric and Infectious Disease Unit, Bambino Gesù Children's Hospital, Institute for Research and Health Care (IRCCS), Rome, Italy.

出版信息

Mediterr J Hematol Infect Dis. 2018 Jun 20;10(1):e2018037. doi: 10.4084/MJHID.2018.037. eCollection 2018.

DOI:10.4084/MJHID.2018.037
PMID:30002793
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6039088/
Abstract

Kawasaki disease (KD) is an acute, self-limited, inflammatory disease affecting medium-sized arteries and particularly the coronary arteries in about 25% of untreated cases. KD is a clinical diagnosis based on the presence of ≥5 days of fever and the presence of ≥4 of the 5 principal clinical criteria. We described, for the first time to our knowledge, a case of a very early development (on day 1) of typical KD with transient coronary involvement, diagnosed on day 2 of disease and treated with aspirin and steroids on day 3, with complete resolution of clinical signs and coronary involvement.

摘要

川崎病(KD)是一种急性、自限性炎症性疾病,可累及中等大小动脉,在约25%未经治疗的病例中尤其会累及冠状动脉。KD是一种基于发热≥5天以及5项主要临床标准中存在≥4项来做出的临床诊断。据我们所知,我们首次描述了一例典型KD极早期(第1天)发病且伴有短暂性冠状动脉受累的病例,该病例在疾病第2天确诊,并于第3天接受阿司匹林和类固醇治疗,临床症状和冠状动脉受累完全消退。